[Clarithromycin for community-acquired pneumonia in adults: focus on anti-inflammatory properties].
A I SinopalnikovSvetlana RachinaI S VasilyevaN A PigusovaO Y KarpovaPublished in: Terapevticheskii arkhiv (2023)
The results of the study are consistent with literature data indicating a rapid decrease in inflammatory markers when clarithromycin is administered to patients with sCAP. Its results can be a starting point for comparative randomized trials assessing both clinical outcomes and immunological parameters when using different classes of antibiotics for the treatment of sCAP.